Stein G M, Schaller G, Pfüller U, Schietzel M, Büssing A
University Witten/Herdecke, Department of Applied Immunology, Communal Hospital, Germany.
Anticancer Res. 1999 Mar-Apr;19(2A):1037-42.
Extracts from European mistletoe (Viscum album L.) are applied in adjuvant cancer treatment, and some components, especially the mistletoe lectins (ML) have been immunologically characterised, but not the thionins, termed viscotoxins (VT).
The influence of the VT on human granulocytes was studied by flow cytometry: E.coli co-stimulated respiratory burst by oxidation of dihydrorhodamine 123 to rhodamine 123 and phagocytosis by ingestion of FITC-labelled E.coli.
VT (25 and 250 micrograms/ml), in contrast to ML, significantly enhanced phagocytosis and burst activity. VT-rich mistletoe extracts also exerted significant effects. In addition, E.coli-activated granulocytes positively stain with Annexin-V and propidium iodide only due to 250 micrograms/ml VT incubation, suggesting that at this concentration burst activity was induced by the physiological activity of granulocytes after microbial ingestion and also by cytotoxic effects.
Viscotoxins exert yet unknown strong immunomodulatory effects on human granulocytes, which might be of benefit for tumour patients, in addition to their cytotoxic properties.
欧洲槲寄生(白果槲寄生)提取物应用于癌症辅助治疗,一些成分,尤其是槲寄生凝集素(ML)已进行了免疫学特性鉴定,但硫堇类物质(称为槲寄生毒素,VT)尚未进行鉴定。
采用流式细胞术研究VT对人粒细胞的影响:大肠杆菌通过将二氢罗丹明123氧化为罗丹明123共同刺激呼吸爆发,并通过摄取异硫氰酸荧光素标记的大肠杆菌进行吞噬作用。
与ML不同,VT(25和250微克/毫升)显著增强吞噬作用和爆发活性。富含VT的槲寄生提取物也有显著作用。此外,仅在250微克/毫升VT孵育后,大肠杆菌激活的粒细胞用膜联蛋白-V和碘化丙啶呈阳性染色,这表明在此浓度下,微生物摄取后粒细胞的生理活性以及细胞毒性作用均诱导了爆发活性。
槲寄生毒素对人粒细胞具有尚未明确的强大免疫调节作用,除了其细胞毒性特性外,这可能对肿瘤患者有益。